Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Anal Chem ; 96(11): 4377-4384, 2024 03 19.
Artigo em Inglês | MEDLINE | ID: mdl-38442207

RESUMO

Low number of circulating tumor cells (CTCs) in the blood samples and time-consuming properties of the current CTC isolation methods for processing a small volume of blood are the biggest obstacles to CTC usage in practice. Therefore, we aimed to design a CTC dialysis system with the ability to process cancer patients' whole blood within a reasonable time. Two strategies were employed for developing this dialysis setup, including (i) synthesizing novel in situ core-shell Cu ferrites consisting of the Cu-CuFe2O4 core and the MIL-88A shell, which are targeted by the anti-HER2 antibody for the efficient targeting and trapping of CTCs; and (ii) fabricating a microfluidic system containing a three-dimensional (3D)-printed microchannel filter composed of a polycaprolactone/Fe3O4 nanoparticle composite with pore diameter less than 200 µm on which a high-voltage magnetic field is focused to enrich and isolate the magnetic nanoparticle-targeted CTCs from a large volume of blood. The system was assessed in different aspects including capturing the efficacy of the magnetic nanoparticles, CTC enrichment and isolation from large volumes of human blood, side effects on blood cells, and the viability of CTCs after isolation for further analysis. Under the optimized conditions, the CTC dialysis system exhibited more than 80% efficacy in the isolation of CTCs from blood samples. The isolated CTCs were viable and were able to proliferate. Moreover, the CTC dialysis system was safe and did not cause side effects on normal blood cells. Taken together, the designed CTC dialysis system can process a high volume of blood for efficient dual diagnostic and therapeutic purposes.


Assuntos
Compostos Férricos , Nanoestruturas , Células Neoplásicas Circulantes , Humanos , Células Neoplásicas Circulantes/patologia , Microfluídica , Medicina de Precisão , Separação Celular/métodos , Diálise Renal , Impressão Tridimensional , Fenômenos Magnéticos , Linhagem Celular Tumoral
2.
Sci Rep ; 12(1): 8382, 2022 05 19.
Artigo em Inglês | MEDLINE | ID: mdl-35589742

RESUMO

Droplet microfluidic has been established to synthesize and functionalize micro/nanoparticles for drug delivery and screening, biosensing, cell/tissue engineering, lab-on-a-chip, and organ-on-a-chip have attracted much attention in chemical and biomedical engineering. Chitosan (CS) has been suggested for different biomedical applications due to its unique characteristics, such as antibacterial bioactivities, immune-enhancing influences, and anticancer bioactivities. The simulation results exhibited an alternative for attaining visions in this complex method. In this regard, the role of the flow rate ratio on the CS droplet features, including the generation rate and droplet size, were thoroughly described. Based on the results, an appropriate protocol was advanced for controlling the CS droplet properties for comparing their properties, such as the rate and size of the CS droplets in the microchip. Also, a level set (LS) laminar two-phase flow system was utilized to study the CS droplet-breaking process in the Flow Focused-based microchip. The outcomes demonstrated that different sizes and geometries of CS droplets could be established via varying the several parameters that validated addressing the different challenges for several purposes like drug delivery (the droplets with smaller sizes), tissue engineering, and cell encapsulation (the droplets with larger sizes), lab-on-a-chip, organ-on-a-chip, biosensing and bioimaging (the droplets with different sizes). An experimental study was added to confirm the simulation results. A drug delivery application was established to verify the claim.


Assuntos
Quitosana , Microgéis , Sistemas de Liberação de Medicamentos , Dispositivos Lab-On-A-Chip , Microfluídica/métodos
3.
Mater Sci Eng C Mater Biol Appl ; 109: 110606, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32228988

RESUMO

Droplet-based microfluidic assisted devices have proposed an extensive interest in many applications such as lab-on-a-chip technologies as well as chemical/biological/nanomaterial preparation, chemical engineering, drug delivery, tissue engineering and biosensing. Here, a computational fluid dynamic model was developed for deep understanding of the droplet size and formation in a flow-focusing (FF) microchannel with consideration of the continuous phase (non-Newtonian fluid). The simulations presented an alternative method to achieve insights into this complicated process. In the following for the first time, the role of channel geometry, channel aspect ratio and flow rate ratio on droplet features including the mechanism of droplet formation, diameter/volume of droplet, velocity/amount of droplet formation, and final shape/size of the generated droplets were fully described. These findings could remarkably derive desirable protocols to control droplets characteristics comprising their size and shape in non-Newtonian fluids. Moreover, level set (LS) method was used for scrutinizing the droplet-breaking procedure in the microfluidic FF devices. The results showed that different droplet sizes could be prepared with changing the various parameters, demonstrating many challenges in various applications including lab-on-a-chip, cell encapsulation, drug delivery, tissue engineering, biosensing and bioimaging could be successfully addressed.


Assuntos
Dispositivos Lab-On-A-Chip , Técnicas Analíticas Microfluídicas , Modelos Teóricos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA